Free Trial

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CI Canadian Convertible Bond ETF Common logo
C$10.36 -0.04 (-0.38%)
As of 08/1/2025 01:18 PM Eastern

CXF vs. CRDL, IPA, APM, GXE, GPH, WMD, EQ, SGW, MDNA, and CGC

Should you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include Cardiol Therapeutics (CRDL), ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), WeedMD (WMD), EQ (EQ), Shoal Games (SGW), Medicenna Therapeutics (MDNA), and Canadian Gold (CGC). These companies are all part of the "pharmaceutical products" industry.

CI Canadian Convertible Bond ETF Common vs. Its Competitors

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

In the previous week, Cardiol Therapeutics had 1 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 2 mentions for Cardiol Therapeutics and 1 mentions for CI Canadian Convertible Bond ETF Common. CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.67 beat Cardiol Therapeutics' score of 0.34 indicating that CI Canadian Convertible Bond ETF Common is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CI Canadian Convertible Bond ETF Common
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardiol Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.75

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CI Canadian Convertible Bond ETF CommonN/A N/A N/A
Cardiol Therapeutics N/A -195.07%-54.15%

Summary

CI Canadian Convertible Bond ETF Common and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically

Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CXF vs. The Competition

MetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE Exchange
Market CapC$52.37MC$763.52MC$2.21BC$6.20B
Dividend Yield4.84%4.84%2.59%6.72%
P/E RatioN/A1.3422.1463.43
Price / SalesN/A25.2083.301,251.00
Price / CashN/A19.5626.0583.29
Price / BookN/A6.7740.024.87
Net IncomeN/A-C$4.28M-C$62.28MC$301.20M
7 Day Performance1.07%-4.26%-2.46%-2.26%
1 Month PerformanceN/A0.54%-0.54%0.81%
1 Year Performance4.65%15.94%26.18%26.63%

CI Canadian Convertible Bond ETF Common Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CXF
CI Canadian Convertible Bond ETF Common
N/AC$10.36
-0.4%
N/A+3.5%C$52.37MN/A0.0090
CRDL
Cardiol Therapeutics
N/AC$1.96
+2.1%
N/A-34.1%C$162.64MN/A-3.8520
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
APM
Andean Precious Metals
2.3913 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
+26.5%C$135.47MC$154.78M2.5530Positive News
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
GPH
Graphite One
N/AC$0.91
flat
N/A+9.2%C$92.14MN/A-13.0920Gap Down
High Trading Volume
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
EQ
EQ
N/AC$0.97
flat
N/A-11.0%C$67.51MC$9.70M-14.4840News Coverage
Gap Down
SGW
Shoal Games
N/AC$0.50
+42.9%
N/A+0.0%C$65.56MC$106.98K-12.5040Gap Up
MDNA
Medicenna Therapeutics
N/AC$0.84
+1.2%
N/A-63.2%C$62.85MC$4.87K-2.3120
CGC
Canadian Gold
N/AC$0.31
+3.4%
N/A+84.4%C$56.53MC$36.51M-10.173,150

Related Companies and Tools


This page (TSE:CXF) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners